Two men have been jailed and another handed a suspended sentence, for selling more than three million doses of prescription-only and unlicensed medicines, including controlled medicines.
Published by Tabula Rasa Healthcare, the report looks at the MedWise Risk Score, technology designed to determine ADE risk rising from medication regimens.
President Donald Trump signed the SUPPORT act granting the FDA additional authority to combat the opioid epidemic, but a pain management CRO argues that opioid addiction isn’t the only crisis.
Bulk pharmaceutical ingredients increasingly used by compounding pharmacies have seen astronomical price hikes over the past two years and now payers are catching on to the trend and stepping in.
Fewer first cycle new drug approvals by the US Food and Drug
Administration (FDA) could be the first evidence of a toughening
regulatory environment, according to new research.
The US Food and Drug Administration (FDA) has come under scrutiny
after an independent report urged the regulator to implement large
reforms to ensure the safety of new prescription drugs.
The move to make pharmaceutical companies more open to scrutiny has
taken a new direction as the US Food and Drug Administration (FDA)
moves to adopt a system that will allow the electronic coding of
crucial terms used in prescription...
New rules detailing an improved format for prescription drug labels
will be issued later this year, US Food and Drug Administration
deputy commissioner for medical and scientific affairs Scott
Gottlieb has said.
A new study has revealed that a commonly used asthma medication
lost more than half its potency after being kept for just four
hours in conditions akin to a mailbox on a hot day. This raises
questions about the efficacy of mail-order...
The US Food and Drug Administration has stepped up its activities
in combating drug counterfeiting by bringing charges against drug
wholesalers for failing to carry out measures designed to safeguard
the pharmaceutical supply chain.